TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial
John Nemunaitis, Zsolt Papai, Hervé Léna, Gyorgy Losonczy, Frederic Forget, Christos Chouaid, Alexandra Szczesna, Radj Gervais, Christian H Ottensmeier, Joseph Beck, Andrzej Kazarnowicz, Virginie Westeel, Didier Debieuvre, Anne Madroszyk, Enriqueta Felip, Jean Marc Limacher, Elisabeth Quoix
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P441; DOI: 10.1186/2051-1426-3-S2-P441